Compound Tripterygium wilfordii multi-glycosides formulation for curing rheumatic disease and preparation method thereof

A technology for tripterygium glycosides and rheumatic diseases, which is applied in the field of compound tripterygium glycosides preparations and its preparation, and can solve problems such as gastrointestinal damage and high toxicity

CN101297841BInactive Publication Date: 2011-08-17JIANGXI HERBFINE HI TECH
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Publication Date
2011-08-17
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a compound tripterygium glycoside preparation for treatment for rheumatic diseases and a preparation method thereof. The invention takes tripterygium glycoside and artemether as main drugs and is in combination with pharmaceutical excipients, microcrystalline cellulose, lactose, low-substituted hydroxyproxyl cellulose, tiny powder silica gel and magnesium stearate for preparing tablets. The weight ratio is that: 5g of tripterygium glycoside and 5 to 30g of artemether. The invention proposes to allow the tripterygium glycoside and the artemether to be compatible to realize the synergy of the efficacies, and the compatibility of the tripterygium glycoside and the artemether has higher treatment effects on rheumatic diseases than that of the tripterygium glycoside.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a preparation for treating rheumatic diseases and a preparation method thereof. In particular, a compound tripterygium glycoside preparation containing tripterygium glycosides and a preparation method thereof. Background technique

[0002] Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, because the abnormality of immune cells causes synovial inflammation and hyperplasia, accompanied by a large number of inflammatory factors, thus causing bone and joint damage irreversible damage. Clinical subjective symptoms include limb joint pain and morning stiffness, and pathological examination shows the destruction of joint bone.

[0003] RA is a common disease that can occur in people of all age groups, and the incidence rate increases with age. According to the survey, there are about 400 million patients with rheumatism in the world, which is the largest type of disease in the medical field. In Ch...

Examples

Embodiment 1

[0057] Example 1 A compound tripterygium glycoside preparation for treating rheumatic diseases, which is a preparation made from tripterygium glycosides and artemether.

Embodiment 2

[0058] Example 2 A compound tripterygium glycosides preparation for treating rheumatic diseases, its weight ratio is: 5 grams of tripterygium glycosides; artemether: 5-30 grams.

Embodiment 3

[0059] Example 3 A compound tripterygium glycosides preparation for treating rheumatic diseases, the weight ratio of which is: 5 grams of tripterygium glycosides; artemether: 20-30 grams.